Genomic epidemiology of SARS-CoV-2 infections in The Gambia, March 2020 to Jan 2022 (2022)

First Author: Kanteh A

Attributed to: SUPPLEMENTARY FUNDING OFFER FOR THE MRC UNIT, THE GAMBIA AT LSHTM (resource to support a clinical trial of Hydroxychloroquine and Azithromycin, studies on the transmission and antibody dynamics to SARS-CoV-2 infection, and to further support funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2022.09.07.22278739

Publication URI: http://dx.doi.org/10.1101/2022.09.07.22278739

Type: Preprint